Quantcast

Latest Raloxifene Stories

2004-12-01 06:00:13

Research and Markets (http://www.researchandmarkets.com/reports/c10315) has announced the addition of Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward to their offering The osteoporosis and HRT market was valued at $8.3 billion in 2003 and is forecast to grow to $17.9 billion by 2014, driven by a number of novel osteoporosis drug launches before 2009.

2004-11-30 18:00:11

A U.S. study of raloxifene found women had more than a 50 percent reduction in breast cancer incidence beyond the first four years of treatment.

2004-11-30 18:00:11

TUESDAY, Nov. 30 (HealthDayNews) -- If you're taking raloxifene (Evista) because you have osteoporosis, a new study finds a probable added benefit: The drug may also significantly reduce your risk of developing breast cancer. The study, which appears in the Dec.

2004-11-26 18:00:09

Dr. Jim Mitterando Q - I am 61 years old. Should I have a bone density test for osteoporosis and take calcium pills? A - Diagnosing and treating osteoporosis (thin bones) is somewhat controversial with many opinions and not much long-term data.


Word of the Day
honeyguide
  • Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.
Honeyguide birds have even been known to eat candles.